NCT03849287View on ClinicalTrials.gov

Compare the Pharmacokinetics and Safety of CKD-333 With Co-administration CKD-330 and D090 in Healthy Male Adults

PHASE1UnknownINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 25, 2019

Primary Completion Date

March 29, 2019

Study Completion Date

April 6, 2019

Conditions
HypertensionDyslipidemias
Interventions
DRUG

CKD-333, formula I

Test drug

DRUG

CKD-333, formula II

Test drug

DRUG

CKD-330, D090

Reference Drug

Trial Locations (1)

Unknown

Seoul Saint Mary's Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY